Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	7.02B
Revenue (ttm)	2.36B
Net Income (ttm)	317.93M
Shares Out	1.50B
EPS (ttm)	0.23
PE Ratio	20.03
Forward PE	10.87
Dividend	0.07 (1.46%)
Ex-Dividend Date	n/a

Volume	6,418,194
Average Volume	12,284,494
Open	4.560
Previous Close	4.560
Day's Range	4.570 - 4.670
52-Week Range	1.850 - 4.880
Beta	0.26
RSI	56.43
Earnings Date	May 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.